Steven Kelly
Vorstandsvorsitzender bei CARISMA THERAPEUTICS, INC.
Vermögen: 1 118 $ am 30.04.2024
Profil
Steven Kelly is the founder of CTx Operations, Inc. (founded in 2018) where he holds the title of President, Chief Executive Officer & Director.
He is currently the President, Chief Executive Officer & Director at Carisma Therapeutics, Inc. (since 2018) and an Independent Director at Artelo Biosciences, Inc. (since 2017).
Previously, he held the position of President & Chief Executive Officer at Innovive Pharmaceuticals, Inc. (2004-2010), President & Chief Executive Officer at Pinteon Therapeutics, Inc. (2014-2015), Chief Executive Officer at Theracrine, Inc. (2011-2012), and Chief Commercial Officer at BioVex, Inc. He also founded Kelly Bioconsulting LLC (2012-2018) where he served as Principal.
Mr. Kelly holds an MBA from Cornell University and an undergraduate degree from the University of Oregon.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARTELO BIOSCIENCES INC
0,03% | 22.03.2024 | 834 ( 0,03% ) | 1 118 $ | 30.04.2024 |
| 31.01.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Steven Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 02.05.2017 |
| CARISMA THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.02.2018 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Gründer | 23.04.2018 |
Ehemalige bekannte Positionen von Steven Kelly
| Unternehmen | Position | Ende |
|---|---|---|
Kelly Bioconsulting LLC
 Kelly Bioconsulting LLC Miscellaneous Commercial ServicesCommercial Services Kelly Bioconsulting LLC provides business consulting services. The private company is based in Boulder. | Corporate Officer/Principal | 01.01.2018 |
Pinteon Therapeutics, Inc.
 Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Vorstandsvorsitzender | 01.07.2015 |
Theracrine, Inc.
 Theracrine, Inc. BiotechnologyHealth Technology Theracrine, Inc. develops anti-metastatic drugs for cancer therapeutics. It provides scientific and technological services as well as research and design relating thereto. The company was founded by David A. Berry, Noubar B. Afeyan, Robert A. Weinberg, Joan Massagué and Douglas Hanahan in 2006 and is headquartered in Cambridge, MA. | Vorstandsvorsitzender | 01.08.2012 |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Präsident | 11.10.2010 |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Corporate Officer/Principal | - |
Ausbildung von Steven Kelly
| Cornell University | Masters Business Admin |
| University of Oregon | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ARTELO BIOSCIENCES, INC. | Health Technology |
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
Pinteon Therapeutics, Inc.
Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA. | Health Technology |
Kelly Bioconsulting LLC
Kelly Bioconsulting LLC Miscellaneous Commercial ServicesCommercial Services Kelly Bioconsulting LLC provides business consulting services. The private company is based in Boulder. | Commercial Services |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Theracrine, Inc.
Theracrine, Inc. BiotechnologyHealth Technology Theracrine, Inc. develops anti-metastatic drugs for cancer therapeutics. It provides scientific and technological services as well as research and design relating thereto. The company was founded by David A. Berry, Noubar B. Afeyan, Robert A. Weinberg, Joan Massagué and Douglas Hanahan in 2006 and is headquartered in Cambridge, MA. | Health Technology |
